Ultrasound-Guided Quadro-Iliac Plane Block for Pain Management After Total Hip Arthroplasty

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorBursa City Hospital

About this trial

This prospective, randomized, double-blind study evaluates the analgesic effectiveness of the ultrasound-guided Quadro-Iliac Plane (QIP) block in patients undergoing primary total hip arthroplasty. The QIP block is a recently described fascial plane block. Patients will be randomized to receive either a QIP block with local anesthetic or a sham block with saline. The primary outcome is 24-hour opioid consumption. Secondary outcomes include motor block, dermatomal sensory assessment, pain scores, rescue analgesic requirement, quality of recovery (QoR-15), and opioid-related side effects.

Eligibility criteria

Qualifiers

American Society of Anesthesiologists (ASA) classification I-III

Age between 18 and 80 years

Patients scheduled for elective primary total hip arthroplasty

Disqualifiers

Refusal to participate in the study

Allergy to local anesthetics or opioids

Known or suspected coagulopathy

Infection at the injection site

Trial design

Treatments tested in this trial

  • Quadro-Iliac Plane (QIP) Block
  • Sham Block

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators